A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway.

MLA

Tan, Yanhui, et al. “A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing C-Fos-NFATc1 Signaling Pathway.” Frontiers in Pharmacology, vol. 12, Jan. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.3389/fphar.2021.753240.

APA

Tan, Y., Ke, M., Li, Z., Chen, Y., Zheng, J., Wang, Y., Zhou, X., Huang, G., & Li, X. (2022). A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway. Frontiers in Pharmacology, 12, 1–11. https://doi.org/10.3389/fphar.2021.753240

Chicago

Tan, Yanhui, Minhong Ke, Zhichao Li, Yan Chen, Jiehuang Zheng, Yiyuan Wang, Xuefeng Zhou, Gang Huang, and Xiaojuan Li. 2022. “A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing C-Fos-NFATc1 Signaling Pathway.” Frontiers in Pharmacology 12 (January): 1–11. doi:10.3389/fphar.2021.753240.